Official Journal of the European Union
DECISION OF THE EEA JOINT COMMITTEE
of 8 July 2005
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,
Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 60/2005 of 29 April 2005 (1).
Commission Regulation (EC) No 2232/2004 of 23 December 2004 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards altrenogest, beclomethasone dipropionate, cloprostenol, r-cloprostenol, sorbitan sesquioleate and toltrazuril (2) is to be incorporated into the Agreement,
HAS DECIDED AS FOLLOWS:
The following indent shall be added in point 14 (Council Regulation (EEC) No 2377/90) of Chapter XIII of Annex II to the Agreement:
32004 R 2232: Commission Regulation (EC) No 2232/2004 of 23 December 2004 (OJ L 379, 24.12.2004, p. 71).’
The text of Regulation (EC) No 2232/2004 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
This Decision shall enter into force on 9 July 2005, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (3).
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 8 July 2005.
For the EEA Joint Committee
HSH Prinz Nikolaus von LIECHTENSTEIN
(1) OJ L 239, 15.9.2005, p. 40.
(2) OJ L 379, 24.12.2004, p. 71.
(3) No constitutional requirements indicated.